Abstract
It has been shown that human promyelocytic leukemia cell line HL601 and acute myeloblastic leukemia cell line KG-12 can be induced to terminally differentiate to macrophage-like cells by 12-0-tetradecanoylphorbol-13-acetate (TPA). Because TPA is a potent activator of protein kinase C (PKC) and the enzyme is the only known high affinity receptor for the tumor promoter3, it is likely that the TPA effects are PKC-dependent. TPA, however, is ineffective in inducing differentiation of a HL60 subline HL60BII4 and a KG-1 subline KG-1a5. The molecular mechanisms underlying the responsiveness or resistance to the differentiating effect of TPA remain unclear. The density and affinity of cell surface receptors for phorbol ester appear to be uninvolved, because there are no significant differences in the binding properties of phorbol ester between KG-1 and KG-1a cells6 or between HL60 and HL60BII cells4. The post-receptor events that occur after binding of TPA to the plasma membrane PKC, which might be distinct for the sublines, perhaps are critical in determining the sensitivity of cells to the differentiating effect of TPA. In this paper we summarize our recent studies on the PKC system in these and other cell lines as well as in developing nervous tissues, aiming to elucidate a role of PKC in cell growth and differentiation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
E. Huberman, and M.F. Callahan, Proc. Natl. Acad. Sci. U.S.A. 76: 293–297 (1979).
H.P. Koeffler, M. Bar-Eli, and M.C. Territo, Cancer Res. 41: 919–926 (1981).
Y. Nishizuka, Nature (London) 308: 693–698 (1984).
J.B. Weinberg, M.A. Misukonis, and B.J. Goodwin, Cancer Res. 44: 976–980 (1984).
H.P. Koeffler, P. Billing, A.J. Lusis, R. Sparkes, and D.W. Golde, Blood, 56: 265–273 (1980).
R.I. Lehrer, L.E. Cohen, and H.P. Koeffler, Cancer Res., 43: 3563–3566 (1983).
M. Shoji, P.R. Girard, P.A. Charp, H.P. Koeffler, W.R. Vogler, and J.F. Kuo, Cancer Res. 47: 6363–6370 (1987).
M. Shoji, P.R. Girard, G.J. Mazzei, W.R. Vogler, and J.F. Kuo, Biochem. Biophys. Res. Commun. 135: 1144–1149 (1986).
P.R. Girard, V.L. Stevens, P.J. Blackshear, A.L. Merrill, J.G. Wood, and J.F. Kuo, Cancer Res. 47: 2892–2898 (1987).
D.L. Halsey, P.R. Girard, J.F. Kuo, and P.J. Blackshear, J. Biol. Chem., 262: 2234–2243 (1987).
B.C. Courcelles, P. Roevens, and H. Van Belle, J. Biol. Chem., 260: 15762–15770 (1985).
Z. Kiss, E. Deli, M. Shoji, H.P. Koeffler, G.R. Pettit, W.R. Vogler, and J.F. Kuo, Cancer Res., 47: 1302–1307 (1987).
D. Kreutter, A.B. Caldwell, and M.J. Morin, J. Biol. Chem., 260: 5979–5984 (1985).
A.H. Merrill, A.M. Sereni, V.L. Stevens, Y.A. Hannun, and R.M. Bell, J. Biol. Chem., 261: 12610–12615 (1986).
S. Capitani, P.R. Girard, G.J. Mazzei, Kou, J.F., Berezney, R., and F.A. Manzoli, Biochem. Biophys. Res. Commun., 142: 367–375 (1987).
J.G. Wood, P.R. Girard, G.J. Mazzei, and J.F. Kuo, J. Neurosci., 6: 2571–2577 (1986).
Z. Kiss, E. Deli, and J.F. Kuo, FEBS Lett., 231: 41–46 (1988).
N. Sahyoun, N. Wolf, J. Besterman, T.S. Hsieh, M. Sander, H. Levine, K.J. Chang, and P. Cuatrecasas, Proc. Natl. Acad. Sci. U.S.A., 83: 1603–1607 (1986).
L.F. Chung, R.H. Cooper, P. Yau, E.M. Bradbury, and R.Y. Chuang, Biochem. Biophys. Res. Comun., 145: 1376–1383 (1987).
A.P. Fields, G.R. Pettit, and W.S. May, J. Biol. Chem., 263: 8253–8260 (1988).
Z. Kiss, E. Deli, and J.F. Kuo, Biochem. J., 248: 649–656 (1987).
R.A. Cooper, A.K. Braunwald, and A.L. Kuo, Proc. Natl. Acad. Sci. U.S.A., 79: 2865–2869 (1982).
Z. Kiss, E. Deli, and J.F. Kuo, Arch. Biochem. Biophys., 265: 000–000 (1988), in press.
E. Deli, Z. Kiss, and J.F. Kuo, FEBS Lett., 231: 407–412 (1988).
S.J. Collins, F.W. Ruscetti, R.B. Gallagher, and R.C. Gallo, Proc. Natl. Acad. Sci. U.S.A., 75: 2458–2462 (1978).
T.R. Breitman, S.E. Selonick, and S.J. Collins, Proc. Natl. Acad. Sci. U.S.A., 77: 2936–2940 (1980).
T.J. Chaplinski, and J.E. Niedel, J. Clin. Invest. 70: 953–964 (1982).
A. Yen, M. Forbes, G. DeGala, and J. Fishbaugh, Cancer Res., 47: 129–134 (1982).
E. Fibach, T. Peled, A. Treves, A. Kornberg, and E. Rachmilewitz, Leukemia Res., 6: 781–790 (1982).
P.R. Girard, J.G. Wood, J.E. Freschi, and J.F. Kuo, Develop. Biol., 126: 98–107 (1988).
W.E. Berdel, R. Andreesen, and P.G. Munder, Synthetic alkyl-phospholipids analogs: A new class of antitumor agents, in: “Phospholipids and Cellular Regulation”, vol. 2, J.F. Kuo, ed., CRC Press, Boca Raton, pp. 41–74 (1985).
Z. Kiss, E. Deli, W.R. Vogler, and J.F. Kuo, Biochem. Biophys. Res. Commun., 142: 661–666 (1987).
K. Oishi, R.L. Raynor, P.A. Charp, and J.F. Kuo, J. Biol. Chem., 263: 6865–6871 (1988).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Kuo, J.F. et al. (1989). Protein Kinase C in Cell Growth and Differentiation. In: Hidaka, H., Carafoli, E., Means, A.R., Tanaka, T. (eds) Calcium Protein Signaling. Advances in Experimental Medicine and Biology, vol 255. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5679-0_2
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5679-0_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5681-3
Online ISBN: 978-1-4684-5679-0
eBook Packages: Springer Book Archive